A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative ...

Uterine cancer develops in the tissues of the uterus, the hollow organ in the pelvis where a fetus could grow and develop during pregnancy. There are two main types of uterine cancer. The most common ...

Soft tissue sarcomas are a rare group of cancers that develop in soft tissue. They can develop almost anywhere in your body, including in your hip, thigh, and groin. Soft tissue sarcomas are rare ...

Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...

At Huntsman Cancer Institute, you receive comprehensive, multidisciplinary care for soft-tissue sarcomas. Our Sarcoma Care Team provides personalized and compassionate care at every step, from ...

Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.

Sarcomas are tumors that form in the body’s connective tissues such as bone, muscle and fat. They are rare and, because there are more than 150 types, patients benefit from seeing a sarcoma specialist ...

The recognition of sarcomas occurring in cancer predisposition syndromes is critical, with implications not only for the index patient but also potentially for family members, including the need for ...

Kaposi sarcoma-associated herpesvirus testing is not routinely performed on donors or reci ...

Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults. While it can be cured if completely removed by surgery, recurrence or metastasis, the ...

Iovance Biotherapeutics reported early pilot trial results for lifileucel in aggressive soft tissue sarcomas. The company plans to start a registrational trial and seek expedited FDA approval based on ...

SARC has today launched a new resource for patients and caregivers, helping to facilitate access to expert sarcoma programs for more accurate, timely, and informed diagnoses and treatments for rare ...